Status TETRA clinical trial, Project ID: 681027

Leonid Schneider made this access to documents request to Research and Innovation

Waiting for an internal review by Research and Innovation of their handling of this request.

From: Leonid Schneider

Delivered

Dear Research and Innovation,

Under the right of access to documents in the EU treaties, as developed in Regulation 1049/2001, I am requesting documents which contain the following information:

The current progress status, including ethical evaluation of the TETRA clinical trial, Project ID: 681027
http://cordis.europa.eu/project/rcn/1987...

My email inquiry to EU spokesperson was deliberately ignored. Here their past information from September 2016:
“The TETRA consortium is obliged to send a comprehensive report on clinical trial status to the European Commission every six months, in addition to periodic project progress reports. As the TETRA project started on 01 January 2016, one such report has already been received, subjected to close inspection by the European Commission and deemed satisfactory.
Ethics checks will also take place before the start of the planned clinical trial and mid-term. The ethics review is foreseen before the TETRA patient recruitment, which is scheduled to begin in July 2018”.
Source:
https://forbetterscience.com/2016/11/18/...

I wish to ask about the outcome of ethics reviews and all other evaluations TETRA experienced.
I would like to receive the evaluation reports.
Also please provide detailed information at which stage TETRA is now, as well as how much money has been already paid out.

Yours faithfully,

Leonid Schneider

Link to this

From: EC ARES NOREPLY
Research and Innovation


Attachment image001.gif
3K Download


Link: [1]File-List
Link: [2]Edit-Time-Data
Link: [3]themeData
Link: [4]colorSchemeMapping

[5]Ares(2017)3334331 - FW: access to documents request - Status TETRA
clinical trial, Project ID: 681027

Sent by RTD ACCESS DOCUMENTS <[email address]>. All
responses have to be sent to this email address.
Envoyé par RTD ACCESS DOCUMENTS <[email address]>.
Toutes les réponses doivent être effectuées à cette adresse électronique.

Dear Mr. Schneider,

 

Thank you for your request for access to documents.

 

Unfortunately you have not indicated your postal address that is required
for registering and handling your request in line with the procedural
requirements. Please send us your full postal address at your earliest
convenience. Pending your reply, we reserve the right to refuse the
registration of your request.

 

Please send us all correspondence to the following email address:
[6][email address]. You also may, of course, use
directly the electronic form for entering your request:
[7]http://ec.europa.eu/transparency/regdoc/...

 

Thank you very much in advance.

 

Yours faithfully,

 

The access to documents team

 

[8]cid:image001.gif@01D2EB6C.0291F180

European Commission

DG Research & Innovation

Unit J1

 

ORBN 10

1049 Brussels/Belgium

[9]http://ec.europa.eu/research

[10]https://twitter.com/EUScienceInnov  

[11]https://www.facebook.com/EUScienceInnov/

 

 

show quoted sections

Link to this

From: Leonid Schneider

Delivered

Dear EC ARES NOREPLY,

My postal address is:

Taunusstr 11
63526 Erlensee
Germany

Yours sincerely,

Leonid Schneider

Link to this

From: EC ARES NOREPLY
Research and Innovation


Attachment image001.gif
3K Download


Link: [1]File-List
Link: [2]Edit-Time-Data
Link: [3]themeData
Link: [4]colorSchemeMapping

[5]Ares(2017)3632747 - Reminder - Your access to documents request -
Status TETRA clinical trial, Project ID: 681027

Sent by RTD ACCESS DOCUMENTS <[email address]>. All
responses have to be sent to this email address.
Envoyé par RTD ACCESS DOCUMENTS <[email address]>.
Toutes les réponses doivent être effectuées à cette adresse électronique.

Dear Mr. Schneider,

 

We refer to your access to documents request submitted on 3 July 2017 to
DG RTD via the AsktheEU.org website and to our request for receiving your
postal address that we sent you on the same day (see original emails
below).

 

Up to this date we have not yet received your reply in the indicated email
address for correspondence ([6][email address]). We
therefore kindly urge you to please provide your postal address, so as to
enable us to duly register and deal with your initial application for
access to documents in the meaning of Article 6(1) of Regulation 1049/2001
otherwise we will proceed to close your request.

 

Please note that the deadline for handling your initial request shall run
only as from the moment of the registration of your request following the
submission of a valid postal address.

 

Thank you in advance.

 

The access to documents team

 

European Commission

DG Research & Innovation

Unit J1

 

ORBN 10

1049 Brussels/Belgium

[7]http://ec.europa.eu/research

[8]https://twitter.com/EUScienceInnov  

[9]https://www.facebook.com/EUScienceInnov/

 

From: EC ARES NOREPLY [mailto:[email address]]
Sent: Monday, July 03, 2017 5:12 PM
To: [FOI #4434 email]
Cc: RTD ACCESS DOCUMENTS
Subject: Ares(2017)3334331 - FW: access to documents request - Status
TETRA clinical trial, Project ID: 681027

 

[10]Ares(2017)3334331 - FW: access to documents request - Status TETRA
clinical trial, Project ID: 681027

 

Sent by RTD ACCESS DOCUMENTS <[11][email address]>. All
responses have to be sent to this email address.

Envoyé par RTD ACCESS DOCUMENTS <[12][email address]>.
Toutes les réponses doivent être effectuées à cette adresse électronique.

 

Dear Mr. Schneider,

 

Thank you for your request for access to documents.

 

Unfortunately you have not indicated your postal address that is required
for registering and handling your request in line with the procedural
requirements. Please send us your full postal address at your earliest
convenience. Pending your reply, we reserve the right to refuse the
registration of your request.

 

Please send us all correspondence to the following email address:
[13][email address]. You also may, of course, use
directly the electronic form for entering your request:
[14]http://ec.europa.eu/transparency/regdoc/...

 

Thank you very much in advance.

 

Yours faithfully,

 

The access to documents team

 

[15]cid:image001.gif@01D2EB6C.0291F180

European Commission

DG Research & Innovation

Unit J1

 

ORBN 10

1049 Brussels/Belgium

[16]http://ec.europa.eu/research

[17]https://twitter.com/EUScienceInnov  

[18]https://www.facebook.com/EUScienceInnov/

 

 

show quoted sections

Link to this

From: Leonid Schneider

Delivered

Dear EC ARES NOREPLY,

you already received my postal address several times, incl this same information request. Here it is again, below. To avoid you losing it again, I submitted another request at your regdoc site.
Leonid Schneider
Taunusstr 11
63526 Erlensee
Germany

Yours sincerely,

Leonid Schneider

Link to this

From: Leonid Schneider

Delivered

Dear EC ARES NOREPLY,

Please kindly reply to my FOIA inquiry. You received my postal address several times already, that excuse is void.

Yours sincerely,

Leonid Schneider

Link to this

From: Leonid Schneider

Delivered

Dear EC ARES NOREPLY,

I received this email on August 8th:
"Dear Sir,
We refer to your email dated 18/07/2017 in which you made a request for access to documents, which was registered on the same day under reference number GestDem 2017/4239. Your application is currently being handled. However, we will not be in a position to complete the handling of your application within the time limit of 15 working days, which expires tomorrow 09/08/2017.
An extended time limit is needed as your application requires the consultation of several services.
Therefore, we have to extend the time limit with 15 working days in accordance with Article 7(3) of Regulation (EC) No 1049/2001 regarding public access to documents. The new time limit expires on 31/08/2017.
We apologize for this delay and for any inconvenience this may cause.
Yours faithfully,
The access to documents team
European Commission
DG Research & Innovation
Unit J1"

Today is August 31st, and the deadline expired. The EU commission simply chose to ignore my inconvenient inquiry.
I wish to lodge a complaint.
Yours sincerely,

Leonid Schneider

Link to this

Things to do with this request

Anyone:
Research and Innovation only: